Sort
16,300 grants matching “fatty liver disease”
Metabolic Characterization of the Novel Adipokine CTRP3
$19,365Jonathan M Peterson · Johns Hopkins University · F32 · FY2011 · DK
Non-alcoholic Fatty Liver Disease and Cardiovascular Disease in Hispanics/Latinos
$19,326Jorge R Kizer · Northern California Institute/Res/Edu · R01 · FY2022 · HL
Hepatic Rictor Knockout Mouse Model and the Metabolic Syndrome
$19,248Jennifer Marie Rojas · Vanderbilt University · F31 · FY2012 · DK
METHIONINE METABOLISM IN NON-ALCOHOLIC FATTY LIVER DISEASE
$19,242John Michael Edmison · Case Western Reserve University · M01 · FY2006 · RR
The Tissue-Specific Functionality of the Farnesoid X Receptor in NASH Development
$19,239Zakiyah Renee Henry · Rutgers Biomedical And Health Sciences · F31 · FY2024 · DK
HORMONAL REGULATION OF BLOOD PRESSURE
$19,212Michal Laniado Schwartzman · New York Medical College · P01 · FY2012 · HL
Obesity and Adipose Tissue
$19,200Terry L. Sheppard · Keystone Symposia · R13 · FY2025 · DK
Metabolic and Molecular Mechanisms of NAFLD/NASH
$19,200Terry L. Sheppard · Keystone Symposia · R13 · FY2023 · DK
1, 3-DIOL AND KETONE BODY METABOLISM
$19,199Case Western Reserve University · M01 · FY2000 · RR
Altered Lipid Droplet Trafficking: Role in Alcoholic Fatty Liver Disease
$19,000Carol A Casey · University Of Nebraska Medical Center · R01 · FY2012 · AA
Deconstructing Inflammation and Altered Microbiota in Metabolic Syndrome
$18,744Andrew T Gewirtz · Georgia State University · R01 · FY2015 · DK
Investigating the role of Phosphoenolpyruvate Carboxykinase in colon cancer
$18,717Emily Dina Montal · State University New York Stony Brook · F31 · FY2017 · CA
VISCERAL FAT CONTRIBUTION TO VERY LOW DENSITY LIPOPROTEIN (VLDL)-TRIGLYCERIDE
$18,713Elisabet Boersheim · University Of Texas Med Br Galveston · M01 · FY2009 · RR
The Impact of Heat Shock Protein Expression on Inflammation and Insulin Action
$18,685Andrea L Hevener · University Of California Los Angeles · R01 · FY2009 · DK
Glucagon and insulin act cooperatively in the regulation of prandial hepatic glycogen metabolism
$18,347Megan Capozzi · Duke University · K01 · FY2023 · DK
CVD in American Indians: Imaging and Cardiovascular Center
$18,275Richard B Devereux · Weill Medical Coll Of Cornell Univ · R01 · FY2018 · HL
CNS action of appetite suppressant aminosterol
$18,270Rexford S Ahima · University Of Pennsylvania · R01 · FY2009 · DK
The Evolution of PGD addiction in Human Pancreatic Cancer
$18,067Oliver Gene McDonald · Vanderbilt University Medical Center · R01 · FY2021 · CA
Surviving the HIV Epidemic (S/HE) in metropolitan Washington DC - Advancing knowledge through cohort studies
$18,015Seble G Kassaye · Georgetown University · U01 · FY2020 · HL
Obesity and NAFLD: Mechanisms and Therapeutics
$18,000Thale Cross Jarvis · Keystone Symposia · R13 · FY2020 · DK
Neurocognitive and Metabolic Effects of Mild Hypothyroidism
$18,000Mary H. Samuels · Oregon Health & Science University · R01 · FY2010 · DK
Triglycerides and Triglyceride-Rich Particles in Health and Disease
$18,000Andrew D Robertson · Keystone Symposia · R13 · FY2010 · HL
Inter Organ Crosstalk in Non-Alcoholic Steatohepatitis (NASH)
$18,000Thale Cross Jarvis · Keystone Symposia · R13 · FY2021 · DK
A Role of Hypothalamic Dysfunction in Alcoholic Liver Disease
$17,998Christoph Buettner · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · AA
NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)
$17,990Case Western Reserve University · M01 · FY2005 · RR